January 14, 2016

Medical Center-only Limited Submission Opportunity: 2016 Translational Research Award from the V Foundation for Cancer Research

Vanderbilt-Ingram Cancer Center (VICC) has been invited to participate in The V Foundation 2016 Translational Research Award. The award is a $600,000 grant awarded in three annual installments of $200,000. 

VICC may nominate two candidates for this award, if at least one of the two nominee applicants is submitting a research project that focuses on the biological basis of cancer disparities experienced by patients from minority ethnic or racial populations in cancer causes, aggressiveness, treatment or relapse.  Minorities for the purposes of this application are defined as African Americans or people of African descent, Asian Americana and Pacific Islanders and people of Asian descent, Hispanic Americans, Hispanics or Latino/Latina persons and Native Americans and Alaskan Natives. 

Any area of cancer research is permitted.  However, research on cancers that are more prevalent or aggressive in specific ethnic populations is encouraged, but not required. Cancers in which ethnic and racial disparities have previously been shown include: lung and bronchus, colon and rectum, breast, prostate, uterine, cervix, stomach and liver.  The V Foundation will designate at least one of the highest ranked applications as the recipient of a Stuart Scott Memorial Fund Translational Research Award.

Please note: Translational projects should move a novel strategy from the laboratory into a human clinical trial or use specimens from a clinical trial to develop biomarkers or mechanisms. The research should apply in some direct way to human beings. If biomarker research is undertaken, a validation set is essential. A plan for biomarker validation, if applicable, must be included in any proposal. The endpoint of the project should be the planning or initiation of a new clinical trial.

Applicant Eligibility:  By the due date of the application, applicants who will lead proposed research team must have all the following:

o   Be senior scientists who hold a tenure-track faculty position at their cancer research institution. Non-promotable, adjunct, affiliated, temporary, part-time or acting faculty positions are not eligible for principal investigator nomination to lead the Translational Research Team. 

o   Applicants must be either U.S. Citizens or be a permanent legal resident in the U.S.

Anyone interested in being considered as Vanderbilt’s nominee must submit the following (in PDF format) to LSO@vanderbilt.edu  by 5 p.m. on Friday, Feb. 5.

  1. Brief (two-page maximum) research plan including summary budget;
  2. Brief statement of support from department chair/center director;
  3. A brief CV or NIH Biosketch

Submissions should reference the program name in the subject line of the email. 

Once received, all proposals will be forwarded to an internal review committee that will choose the final nominee. The chosen nominee will submit a full proposal to the Foundation by the March 29 deadline.

If you have any questions about the foundation or its interests and priorities, please contact, Janey Wang (janey.wang@vanderbilt.edu), program manager, Office of Research (615-322-0522).